Thrombomodulin Gene Polymorphism (C1418T) is Associated with the Development of Coronary Allograft Vasculopathy

Abstract

Thrombomodulin (TM) is the endothelial cell membrane-bound anticoagulant protein cofactor in the thrombin-mediated activation of protein C. Previous evidence has been reported regarding the association between TM polymorphisms and coronary artery disease. Allograft rejection-mediated vasculopathy is the main cause of death at more than one year after heart transplantation. However, whether TM polymorphism is associated with allograft rejection is still unclear. We analyzed the TM gene polymorphism C1418T using allele-specific primers in a PCR assay in 60 patients who underwent heart transplantation. The retrospective clinical data were collected and tested for any correlations with the TM gene polymorphism. We separated the patients into 2 groups according to their TM genotype (group 1: CC genotype; group 2: CT or TT genotype). Additionally, we generated expression constructs (TM full length-C1418 and TM full length-T1418) and performed in vitro studies to explore the correlation between the TM C1418T polymorphism and the migration of smooth muscle progenitor cells and monocytes, which may be involved in the development of vasculopathy. The results showed that the levels of CD68, C4d, PAS, and Masson staining in the CT/TT genotype group increased at year 1 and continued to increase throughout the 3 years. These levels were higher than those observed in the CC genotype group. The ISHLT-WF2004 grade of the CT/TT genotype group was significantly different from that of the CC genotype group at the same time point post-transplantation. The coronary allograft vasculopathy (CAV) score was significantly different between the CC and CT/TT genotype groups at 1 and 3 years post-transplantation. Our in vitro studies demonstrate that both smooth muscle progenitor cells and monocytic THP-1 cells with either the CT-1418 or the TT-1418 TM genotype have higher migratory abilities than cells with the CC-1418 genotype. Our results support a significant association between the TM C1418T polymorphism and the development of CAV after heart transplantation in the short- to medium-term.

Keywords

thrombomodulin allograft rejection heart transplantation

References

Esmon

. Inflammation and thrombosis. J Thromb Haemost 2003; 1:1343–8.

Koutsi

Papapanagiotou

Papavassiliou

. Thrombomodulin: From haemostasis to inflammation and tumourigenesis. Int J Biochem Cell Biol 2008; 40:1669–73.

Aleksic

Ahn

Boerwinkle

Folsom

Juneja

. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease. Circulation 2001; 103:1386–9.

Ireland

Kunz

Kyriakoulis

Stubbs

Lane

. Thrombomodulin gene mutations associated with myocardial infarction. Circulation 1997; 96:15–8.

Chen

Yeh

. Functional mutation in the promoter region of thrombomodulin gene in relation to carotid atherosclerosis. Atherosclerosis 2001; 154:713–9.

Chen

Tsai

Chao

Guo

Tsai

Shi

. Synergistic effect of thrombomodulin promoter -33G/A polymorphism and smoking on the onset of acute myocardial infarction. Thromb Haemost 2002; 87:86–91.

Crikis

Zhang

Dezfouli

. Antiinflammatory and anticoagulant effects of transgenic expression of human thrombomodulin in mice. Am J Transplant 2010; 10:242–50.

Michaels

Espejo

Kobashigawa

Alejos

Burch

Takemoto

Reed

Fishbein

. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22:58–69.

Reed

Demetris

Hammond

. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25:153–9.

10.

Kaczmarek

Ertl

Schmauss

Sadoni

Knez

Daebritz

Meiser

Reichart

. Preventing cardiac allograft vasculopathy: Long-term beneficial effects of mycophenolate mofetil. J Heart Lung Transplant 2006; 25:550–56.

11.

Huang

Chen

Tsai

. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol 2010; 30:869–77.

12.

Lin

Tsai

Lee

. TNF-alpha-decreased thrombomodulin expression in monocytes is inhibited by propofol through regulation of tristetraprolin and human antigen R activities. Shock 2011; 36:279–88.

13.

Tang

Morgan

Parker

Ware

. Requirement for protein kinase C theta for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells. J Biol Chem 1997; 272:28704–11.

14.

Simanek

Dowd

Pawelec

Melzer

Dutta

Aiello

. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 2011; 6:e16103.

15.

Schober

Hristov

Kofler

. CD34+CD140b+ cells and circulating CXCL12 correlate with the angiographically assessed severity of cardiac allograft vasculopathy. Eur Heart J 2011; 32:476–84.

16.

Schober

. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008; 28:1950–9.

17.

Welters

Menges

Ballesteros

Knothe

Ruwoldt

Gorlach

Hempelmann

. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease. Thromb Res 1998; 92:1–9.

18.

Conway

Van de Wouwer

Pollefeyt

. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 2002; 196:565–77.

19.

Delvaeye

Noris

De Vriese

. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361:345–57.

20.

Aleksic

Folsom

Cushman

Heckbert

Tsai

. Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: The LITE Study. J Thromb Haemost 2003; 1:88–94.

21.

Le Flem

Picard

Emmerich

Gandrille

Fiessinger

Aiach

Alhenc-Gelas

. Mutations in promoter region of thrombomodulin and venous thromboembolic disease. Arterioscler Thromb Vasc Biol 1999; 19:1098–104.

22.

Chao

Chen

Shi

Tsai

Chen

Liu

. Relation of thrombomodulin gene polymorphisms to acute myocardial infarction in patients <or =50 years of age. Am J Cardiol 2004; 93:204–7.

23.

Park

Nabika

Jang

Kwon

Cho

Masuda

. Association of G-33A polymorphism in the thrombomodulin gene with myocardial infarction in Koreans. Hypertens Res 2002; 25:389–94.

24.

Sugiyama

Hirota

Kimura

. Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population. Thromb Res 2007; 119:35–43.

25.

Ohlin

Norlund

Marlar

. Thrombomodulin gene variations and thromboembolic disease. Thromb Haemost 1997; 78:396–400.

26.

Pepys

Hirschfield

. C-reactive protein: A critical update. J Clin Invest 2003; 111:1805–12.

27.

Dehghan

Kardys

de Maat

. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes 2007; 56:872–8.

28.

Ventura

Mehra

. C-Reactive protein and cardiac allograft vasculopathy. is inflammation the critical link? J Am Coll Cardiol 2003; 42:483–5.

29.

Inoue

Sata

Hikichi

. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: Impact on restenosis. Circulation 2007; 115:553–61.

30.

Reed

Demetris

Hammond

. Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25:153–9.